Status:
UNKNOWN
Personalized Signature of Chronic Inflammation and Early Aging Predictive of the Comorbidities in Infertile Men
Lead Sponsor:
IRCCS San Raffaele
Conditions:
Male Infertility
Eligibility:
MALE
18-50 years
Brief Summary
The aim of the project is identify new biomarkers and/or prognostic factors in order to develop personalized strategies to prevent the onset of tumor and/or non tumor comorbidity in infertile men.
Detailed Description
Infertility is a disease of nearly endemic proportions, affecting up to 15% of couples of reproductive ages. Overall, a pure male factor infertility underlies the problem in at least 30% of cases. Gen...
Eligibility Criteria
Inclusion
- Age \> 18 and \< 50 years;
- White race
- Men with OAT o iNOA infertility diagnosis
- ability to sign the consent information
Exclusion
- inability to sign the consent information
- secondary infertility diagnosis
- history of hematological diseases
- people treated with antibiotics in the six months prior the enrollment
Key Trial Info
Start Date :
June 21 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 20 2025
Estimated Enrollment :
350 Patients enrolled
Trial Details
Trial ID
NCT06082362
Start Date
June 21 2023
End Date
June 20 2025
Last Update
October 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS Ospedale San Raffaele
Milan, Lombardy, Italy, 20132